+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Post-traumatic Stress Disorder Treatment Market Size, Share & Trends Analysis Report By Drug Class, By Demographics (Adult, Children), By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • November 2022
  • Region: Global
  • Grand View Research
  • ID: 5702139
The global post-traumatic stress disorder treatment market size is expected to reach USD 1.4 billion by 2030, registering a CAGR of 4.7% from 2022 to 2030. The increasing disease burden of post-traumatic stress disorder (PTSD), innovation in R&D and emerging drug pipeline, and efforts by government and non-profit organizations to increase awareness are the key factors augmenting the space growth.

The emerging drug pipeline, thereby, expected advancement and drug launches for the treatment of PTSD, is anticipated to offer a lucrative opportunity for market growth over the forecast period. This can be attributed to the presence of Aptinyx’s NYX-783, Bionomics’ BNC210, and Jazz Pharmaceuticals’ JZP150 under phase 2 clinical trials. Ahead of these, Otsuka Pharmaceutical’s Brexpiprazole and Zoloft Combination are in phase 3 trial, creating fierce competition among key players to launch the product in the space.

Events such as the COVID-19 pandemic further support space growth. Several studies have been conducted to understand the impact of the covid 19 pandemic on mental health, increasing the risk of PTSD and rising demand for its treatment. For instance, the August 2021 review article, "COVID?19 and Post traumatic Stress Disorder: The Perfect 'Storm' for Mental Health," clearly demonstrates an increase in the risk of development of PTSD among pandemic affected families and survivors.

Companies are strategically taking initiatives that aid in developing new products, regulatory approvals, and enhancing their product portfolio with geographical expansion. For instance, in March 2022, H. Lundbeck A/S granted the license agreement to Sun Pharmaceutical Industries Ltd., for marketing and distribute of Vortioxetine under the brand name Vortidiftm in the Indian market.

Post-traumatic Stress Disorder Treatment Market Report Highlights

  • In 2021, antidepressants segment accounted for the largest share and is anticipated to maintain its position over the forecast period owing to FDA approved SSRIs such as Zoloft (sertraline) and Paxil (paroxetine)
  • Based on demographics, adult segment is estimated to witness the fastest CAGR of 5.1% during the forecast period owing to presence of rising disorder incidence in adult group, major chunk of patients in this age group and increase in traumatic experiences
  • Based on distribution channel, retail pharmacy segment dominated the space in 2021, due to factors such easy of availability, and its compatibility with homecare setting for the long term treatment
  • Asia Pacific region is anticipated to experience the fastest growth over the forecast period due to an increased awareness among the population, rise in disposable income, and high disease prevalence of PTSD in developing countries

Table of Contents

Chapter 1 Methodology And Scope
1.1 Market Segmentation And Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List Of Secondary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Post-Traumatic Stress Disorder Treatment Market Variables, Trends, And Scope
3.1 Penetration And Growth Prospect Mapping
3.2 User Perspective Analysis
3.3 Regulatory And Reimbursement Framework
3.4 Market Driver Analysis
3.4.1 Rising Prevalence Of The Ptsd
3.4.2 Increasing R&D For Development Of New Therapies
3.5 Market Restraint Analysis
3.5.1 Side Effects Associated With Drugs
3.6 Covid-19 Impact Analysis
3.7 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
3.8 Industry Analysis - Porter’s
Chapter 4 Post-Traumatic Stress Disorder Treatment Market: Segment Analysis, By Drug Class, 2018 - 2030 (USD Million)
4.1 Post-Traumatic Stress Disorder Treatment Market: Drug Class Movement Analysis
4.2 Antidepressants
4.2.1 Antidepressants Market, 2018 - 2030 (USD Million)
4.3 Antipsychotics
4.3.1 Antipsychotics Market, 2018 - 2030 (USD Million)
4.4 Anti-Anxiety
4.4.1 Anti-Anxiety Market, 2018 - 2030 (USD Million)
4.5 Others
4.5.1 Others Market, 2018 - 2030 (USD Million)
Chapter 5 Post-Traumatic Stress Disorder Treatment Market: Segment Analysis, By Demographics, 2018 - 2030 (USD Million)
5.1 Post-Traumatic Stress Disorder Treatment Market: Demographics Movement Analysis
5.2 Adult
5.2.1 Adult Market, 2018 - 2030 (USD Million)
5.3 Children
5.3.1 Children Market, 2018 - 2030 (USD Million)
Chapter 6 Post-Traumatic Stress Disorder Treatment Market: Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)
6.1 Post-Traumatic Stress Disorder Treatment Market: Distribution Channel Movement Analysis
6.2 Hospital Pharmacy
6.2.1 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
6.3 Retail Pharmacy
6.3.1 Retail Pharmacy Market, 2018 - 2030 (USD Million)
6.4 Others
6.4.1 Others Market, 2018 - 2030 (USD Million)
Chapter 7 Post-Traumatic Stress Disorder Treatment Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2021 & 2030
7.3 Regional Market Snapshot
7.4 Market Size, & Forecasts, Revenue And Trend Analysis, 2021 to 2030
7.4.1 North America
7.4.1.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4.1.2 U.S.
7.4.1.2.1 U.S. Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
7.4.1.3 Canada
7.4.1.3.1 Canada Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
7.4.2 Europe
7.4.2.1 Europe Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
7.4.2.2 U.K.
7.4.2.2.1 Uk Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
7.4.2.3 Germany
7.4.2.3.1 Germany Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
7.4.2.4 France
7.4.2.4.1 France Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
7.4.2.5 Spain
7.4.2.5.1 Spain Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
7.4.2.6 Italy
7.4.2.6.1 Italy Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
7.4.3 Asia Pacific
7.4.3.1 Asia Pacific Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
7.4.3.2 Japan
7.4.3.2.1 Japan Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
7.4.3.3 China
7.4.3.3.1 China Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
7.4.3.4 India
7.4.3.4.1 India Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
7.4.3.5 Australia
7.4.3.5.1 Australia Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
7.4.3.6 South Korea
7.4.3.6.1 South Korea Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
7.4.4 Latin America
7.4.4.1 Latin America Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
7.4.4.2 Brazil
7.4.4.2.1 Brazil Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
7.4.4.3 Mexico
7.4.4.3.1 Mexico Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
7.4.4.4 Argentina
7.4.4.4.1 Argentina Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
7.4.5 Middle East & Africa
7.4.5.1 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
7.4.5.2 South Africa
7.4.5.2.1 South Africa Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
7.4.5.3 Saudi Arabia
7.4.5.3.1 Saudi Arabia Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
7.4.5.4 UAE
7.4.5.4.1 UAE Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
Chapter 8 Post-Traumatic Stress Disorder Treatment Market: Competitive Analysis
8.1 Recent Developments And Impact Analysis, By Key Market Participants
8.1.1 New Product Launches
8.1.2 Mergers And Acquisitions
8.1.3 Partnerships And Strategic Collaboration
8.1.4 Conferences And Campaigns
8.2 Company Categorization
8.2.1 Innovators
8.2.2 Market Leaders
8.2.3 Heat Map Analysis
8.3 Vendor Landscape
8.3.1 List Of Key Distributors And Channel Partners
8.3.2 Key Customers
8.4 Key Company Market Share Analysis, 2021
8.5 Public Companies
8.5.1 Company Market Position Analysis
8.5.2 Competitive Dashboard Analysis
8.5.2.1 Market Differentiators
8.6 Private Companies
8.6.1 List Of Key Emerging Companies
8.6.2 Regional Network Map
8.7 Company Profiles
8.7.1 Lupin Limited
8.7.1.1 Company Overview
8.7.1.2 Financial Performance
8.7.1.3 Product Benchmarking
8.7.1.4 Strategic Initiatives
8.7.2 Pfizer, Inc.
8.7.2.1 Company Overview
8.7.2.2 Financial Performance
8.7.2.3 Product Benchmarking
8.7.2.4 Strategic Initiatives
8.7.3 Aurobindo Pharma Limited
8.7.3.1 Company Overview
8.7.3.2 Financial Performance
8.7.3.3 Product Benchmarking
8.7.3.4 Strategic Initiatives
8.7.4 Merck Kgaa
8.7.4.1 Company Overview
8.7.4.2 Financial Performance
8.7.4.3 Product Benchmarking
8.7.4.4 Strategic Initiatives
8.7.5 Glaxosmithkline Plc
8.7.5.1 Company Overview
8.7.5.2 Financial Performance
8.7.5.3 Product Benchmarking
8.7.5.4 Strategic Initiatives
8.7.6 Otsuka Pharmaceutical Development
8.7.6.1 Company Overview
8.7.6.2 Financial Performance
8.7.6.3 Product Benchmarking
8.7.6.4 Strategic Initiatives
8.7.7 Jazz Pharmaceuticals
8.7.7.1 Company Overview
8.7.7.2 Financial Performance
8.7.7.3 Product Benchmarking
8.7.7.4 Strategic Initiatives
8.7.8 Bionomics
8.7.8.1 Company Overview
8.7.8.2 Financial Performance
8.7.8.3 Product Benchmarking
8.7.8.4 Strategic Initiatives
8.7.9 Aptinyx
8.7.9.1 Company Overview
8.7.9.2 Financial Performance
8.7.9.3 Product Benchmarking
8.7.9.4 Strategic Initiatives
8.7.10 Astrazeneca
8.7.10.1 Company Overview
8.7.10.2 Financial Performance
8.7.10.3 Product Benchmarking
8.7.10.4 Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviation
Table 3 List of Key Distributors
Table 4 List of Other Companies
Table 5 List of Key Emerging Companies/Demographics Disruptors/innovators
Table 6 Global Post-traumatic Stress Disorder Treatment Market, By Region, 2018 - 2030 (USD Million)
Table 7 Global Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 8 Global Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 9 Global Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 10 North America Post-traumatic Stress Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 11 North America Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 12 North America Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 13 North America Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 14 U.S. Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 15 U.S. Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 16 U.S. Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 17 Canada Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 18 Canada Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 19 Canada Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 20 Europe Post-traumatic Stress Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 21 Europe Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 22 Europe Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 23 Europe Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 24 U.K. Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 25 U.K. Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 26 U.K. Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 27 Germany Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 28 Germany Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 29 Germany Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 30 France Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 31 France Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 32 France Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 33 Spain Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 34 Spain Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 35 Spain Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 36 Italy Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 37 Italy Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 38 Italy Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 39 Asia Pacific Post-traumatic Stress Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 40 Asia Pacific Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 41 Asia Pacific Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 42 Asia Pacific Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 43 Japan Post-traumatic Stress Disorder Treatment Market, By Drug Class Type, 2018 - 2030 (USD Million)
Table 44 Japan Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 45 Japan Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 46 China Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 47 China Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 48 China Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 49 India Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 50 India Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 51 India Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 52 Australia Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 53 Australia Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 54 Australia Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 55 South Korea Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 56 South Korea Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 57 South Korea Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 58 Latin America Post-traumatic Stress Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 59 Latin America Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 60 Latin America Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 61 Latin America Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 62 Brazil Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 63 Brazil Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 64 Brazil Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 65 Mexico Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 66 Mexico Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 67 Mexico Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 68 Argentina Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 69 Argentina Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 70 Argentina Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 71 MEA Post-traumatic Stress Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 72 MEA Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 73 MEA Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 74 MEA Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 75 South Africa Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 76 South Africa Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 77 South Africa Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 78 Saudi Arabia Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 79 Saudi Arabia Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 80 Saudi Arabia Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 81 UAE Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 82 UAE Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
Table 83 UAE Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Post-traumatic stress disorder treatment market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2020)
Fig. 10 Penetration and growth prospect mapping
Fig. 11 User perspective analysis
Fig. 12 Post-traumatic stress disorder treatment market driver impact
Fig. 11 Prevalence of PTSD by WHO regions (in 2021)
Fig. 12 Post-traumatic stress disorder treatment market restraint impact
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Post-traumatic stress disorder treatment market drug class outlook: Key takeaways
Fig. 16 Post-traumatic stress disorder treatment market: Drug class movement analysis
Fig. 17 Antidepressants market, 2018 - 2030 (USD million)
Fig. 18 Antipsychotics market, 2018 - 2030 (USD million)
Fig. 19 Anti-anxiety market, 2018 - 2030 (USD million)
Fig. 20 Others market, 2018 - 2030 (USD million)
Fig. 21 Post-traumatic stress disorder treatment market demographics outlook: Key takeaways
Fig. 22 Post-traumatic stress disorder treatment market: Demographics movement analysis
Fig. 23 Adult market, 2018 - 2030 (USD million)
Fig. 24 Children market, 2018 - 2030 (USD million)
Fig. 25 Post-traumatic stress disorder treatment market distribution channel outlook: Key takeaways
Fig. 26 Post-traumatic stress disorder treatment market: Distribution channel movement analysis
Fig. 27 Hospital pharmacy market, 2018 - 2030 (USD million)
Fig. 28 Retail pharmacy market, 2018 - 2030 (USD million)
Fig. 29 Others market, 2018 - 2030 (USD million)
Fig. 30 Regional outlook, 2021 & 2030
Fig. 31 Regional marketplace: Key takeaways
Fig. 32 North America
Fig. 33 North America post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
Fig. 34 U.S.
Fig. 35 U.S. post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
Fig. 36 Canada
Fig. 37 Canada post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
Fig. 38 Europe
Fig. 39 Europe post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
Fig. 40 U.K.
Fig. 41 U.K. post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
Fig. 42 Germany
Fig. 43 Germany post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
Fig. 44 France
Fig. 45 France post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
Fig. 46 Spain
Fig. 47 Spain post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
Fig. 48 Italy
Fig. 49 Italy post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
Fig. 50 Asia Pacific
Fig. 51 Asia Pacific post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
Fig. 52 Japan
Fig. 53 Japan post-traumatic stress disorder treatment market et, 2018 - 2030 (USD Million)
Fig. 54 China
Fig. 55China post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
Fig. 56 India
Fig. 57 India post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
Fig. 58 Australia
Fig. 59 Australia post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
Fig. 60 South Korea
Fig. 61 South Korea post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
Fig. 62 Latin America
Fig. 63 Latin America post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
Fig. 64 Brazil
Fig. 65 Brazil post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
Fig. 66 Mexico
Fig. 67 Mexico post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
Fig. 68 Argentina
Fig. 69 Argentina post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
Fig. 70 Middle East & Africa
Fig. 71 Middle East & Africa post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
Fig. 72 South Africa
Fig. 73 South Africa post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
Fig. 74 Saudi Arabia
Fig. 75 Saudi Arabia post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
Fig. 76 UAE
Fig. 77 UAE post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
Fig. 78 Heat map analysis
Fig. 79 Company market share analysis (2021)
Fig. 80 Company market position analysis (2021)
Fig. 81 Company market position analysis (2021)
Fig. 82 Market differentiators
Fig. 83 Regional network map

Companies Mentioned

  • Lupin Limited
  • Pfizer, Inc.
  • Aurobindo Pharma Limited
  • Merck Kgaa
  • GlaxoSmithKline plc
  • Otsuka Pharmaceutical Development
  • Jazz Pharmaceuticals
  • Bionomics
  • Aptinyx
  • Astrazeneca

Methodology

Loading
LOADING...

Table Information